SARS-CoV-2 Trifecta

Delivering the Trifecta of Solutions

Streamline your workflow from patient collection to results with your long-term partner in SARS-CoV-2 testing and beyond. 

 

Simplified
Workflow

Superior
Sensitivity1

Scalable
Automation

Collect and load directly on the Panther® system without uncapping or specimen transfer.

Detect with superior sensitivity from a trusted leader in molecular diagnostic testing.

Deliver more results in less time with a high-throughput fully automated instrument.

     
     

Direct Load Capture Cap*

Aptima® SARS-CoV-2 Assay

Panther System

Direct Load Tube*    

 

 

 


* In development and not for sale.
† The Aptima® SARS-CoV-2 assay: This test has not been FDA cleared or approved; This test has been authorized by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C.§ 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Reference: 1. Compared with other high-throughput, fully automated systems. U.S. Food and Drug Administration. SARS-CoV-2 Reference Panel Comparative Data. Last reviewed December 07, 2020. Accessed February 23, 2021. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data
Want Image Slider on Tab Click
no